Norges Bank’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-440,168
Closed -$75.8M 2347
2021
Q3
$75.8M Buy
440,168
+21,820
+5% +$3.76M 0.02% 733
2021
Q2
$52.5M Sell
418,348
-6,675
-2% -$838K 0.01% 938
2021
Q1
$57.6M Sell
425,023
-52,632
-11% -$7.14M 0.01% 898
2020
Q4
$61.1M Hold
477,655
0.01% 841
2020
Q3
$53.8M Buy
477,655
+15,189
+3% +$1.71M 0.01% 808
2020
Q2
$44.1M Sell
462,466
-87,762
-16% -$8.36M 0.01% 917
2020
Q1
$49.4M Hold
550,228
0.02% 704
2019
Q4
$29.2M Buy
550,228
+14,323
+3% +$759K 0.01% 1293
2019
Q3
$21.2M Buy
535,905
+40,260
+8% +$1.59M 0.01% 1451
2019
Q2
$20.4M Buy
495,645
+26,281
+6% +$1.08M 0.01% 1493
2019
Q1
$21.9M Buy
469,364
+66,712
+17% +$3.11M 0.01% 1446
2018
Q4
$17.5M Hold
402,652
0.01% 1481
2018
Q3
$23M Hold
402,652
0.01% 1443
2018
Q2
$19.5M Hold
402,652
0.01% 1543
2018
Q1
$15.7M Hold
402,652
0.01% 1569
2017
Q4
$17.1M Hold
402,652
0.01% 1544
2017
Q3
$15M Buy
402,652
+80,000
+25% +$2.99M 0.01% 1592
2017
Q2
$9.81M Hold
322,652
﹤0.01% 1745
2017
Q1
$8.54M Hold
322,652
﹤0.01% 1784
2016
Q4
$8.23M Hold
322,652
﹤0.01% 1758
2016
Q3
$11.2M Buy
322,652
+132,736
+70% +$4.59M 0.01% 1592
2016
Q2
$6.45M Buy
189,916
+155,116
+446% +$5.27M ﹤0.01% 1793
2016
Q1
$918K Buy
34,800
+4,800
+16% +$127K ﹤0.01% 2070
2015
Q4
$1.46M Hold
30,000
﹤0.01% 2069
2015
Q3
$747K Buy
+30,000
New +$747K ﹤0.01% 2149